RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000020.xml
Geburtshilfe Frauenheilkd 2009; 69(5): R43-R65
DOI: 10.1055/s-0029-1185694
DOI: 10.1055/s-0029-1185694
GebFra-Refresher
© Georg Thieme Verlag KG Stuttgart · New York
Rationelle Diagnostik in der gynäkologischen Endokrinologie und Reproduktionsmedizin – Teil 1: Physiologie und Symptomabklärung
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
28. Mai 2009 (online)
![](https://www.thieme-connect.de/media/gebfra/200905/lookinside/thumbnails/10.1055-s-0029-1185694-1.jpg)
Einleitung
Die
Werden Hormonparameter nicht gezielt und rational bestimmt, kann dies mehr Fragen aufwerfen als beantworten. |
Literatur
-
1 Bettendorf M.
Messbare Veränderungen von Pubertätshormonen: Was ist normal? . Ranke MB, Dörr HG Hypogonadismus in der Adoleszenz. Zwickau; Verlag wissenschaftlicher Scripten 2008: 33-38 -
2 Oppelt P G.
Feminine Entwicklung (Ovarien, Uterus, Mamma). Ranke MB, Dörr HG Hypogonadismus in der Adoleszenz. Zwickau; Verlag wissenschaftlicher Scripten 2008: 13-16 - 3 Oppelt P G, Ünlühan N, Beckmann M W. Kinder- und Jugendgynäkologie. Frauenheilkunde gynup2date. 2007; 3 269-289
-
4 Jung H.
Endokrinologie der Kindheit, Pubertät und Adoleszenz. Leidenberger F, Strowitzki T, Ortman O Klinische Endokrinologie für Frauenärzte. Berlin, Heidelberg, New York; Springer Verlag 2005: 65-78 -
5 Ludwig M.
Primäre Ovarialinsuffizienz. Leidenberger F, Strowitzki T, Ortman O Klinische Endokrinologie für Frauenärzte. Berlin, Heidelberg, New York; Springer Verlag 2005: 287-297 -
6 Dörr H G.
Normale körperliche Entwicklung. Dörr HG, Rascher W Praxisbuch Jugendmedizin. München; Urban & Fischer Verlag 2001: 3-8 - 7 Wolf A S, Esser-Mittag J. Kinder- und Jugendgynäkologie Atlas und Leitfaden für die Praxis. Ulm, Düsseldorf; Schattauer Verlag 2002
- 8 Azziz R, Sanchez L A, Knochenhauer E S, Moran C, Lazenby J, Stephens K C, Taylor K, Boots L R. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004; 89 453-462
- 9 Rosenfield R L. Clinical practice. Hirsutism. N Engl J Med. 2005; 353 2578-2588
- 10 Ferriman D, Gallwey J D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961; 21 1440-1447
- 11 Hatch R, Rosenfield R L, Kim M H, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981; 140 815-830
- 12 Martin K A, Chang R J, Ehrmann D A, Ibanez L, Lobo R A, Rosenfield R L, Shapiro J, Montori V M, Swiglo B A. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008; 93 1105-1120
- 13 Taieb J, Mathian B, Millot F, Patricot M C, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem. 2003; 49 1381-1395
- 14 Rosner W, Auchus R J, Azziz R, Sluss P M, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007; 92 405-413
- 15 Mueller A, Cupisti S, Binder H, Hoffmann I, Kiesewetter F, Beckmann M W, Dittrich R. Endocrinological markers for assessment of hyperandrogenemia in hirsute women. Horm Res. 2007; 67 35-41
- 16 Chang W Y, Knochenhauer E S, Bartolucci A A, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril. 2005; 83 1717-1723
- 17 Mathur R S, Moody L O, Landgrebbe S, Williamson H O. Plasma androgens and sex hormone binding globulin in the evaluation of hirsute patients. Fertil Steril. 1981; 35 29-37
- 18 Vermeulen A, Verdonck L, Kaufman J M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999; 84 3666-3672
- 19 Mueller A, Dittrich R, Binder H, Hoffmann I, Beckmann M W, Cupisti S. Evaluation of recommended markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria. Eur J Med Res. 2006; 11 540-544
- 20 Mueller A, Dittrich A, Cupisti S, Beckmann M W, Binder H. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone. Exp Clin Endocrinol Diabetes. 2006; 114 182-187
- 21 Mueller A, Cupisti S, Binder H, Hoffmann I, Beckmann M W, Dittrich R. The role of albumin in the calculation of free and bioavailable testosterone in women with hyperandrogenemia. In Vivo. 2006; 20 403-407
- 22 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81 19-25
- 23 Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997; 18 774-800
- 24 Cupisti S, Kajaia N, Dittrich R, Duezenli H, Beckmann M W, Mueller A. Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome. Eur J Endocrinol. 2008; 158 711-719
- 25 Kajaia N, Binder H, Dittrich R, Oppelt P G, Flor B, Cupisti S. et al . Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome. Eur J Endocrinol. 2007; 157 499-507
- 26 Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M, Trnovec T, Langer P, Sebokova E, Klimes I. Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes. 2006; 114 249-256
- 27 Matsuda M, DeFronzo R A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22 1462-1470
- 28 Yilmaz M, Bukan N, Ersoy R, Karakoc A, Yetkin I, Ayvaz G, Cakir N, Arslan M. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome. Hum Reprod. 2005; 20 2414-2420
- 29 Ascaso J F, Pardo S, Real J T, Lorente R I, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003; 26 3320-3325
- 30 Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab. 2002; 87 144-147
- 31 Vermeulen A, Verdonck L. Sex hormone concentrations in post-menopausal women. Clin Endocrinol. 1978; 9 59-66
- 37 Pfleiderer A, Breckwoldt M, Kaufmann M. Gynäkologie und Geburtshilfe. 4. Aufl. Stuttgart; Thieme 2002
- 32 Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L A. Longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 1995; 21 103-113
- 33 Döring G K. Über die relative Häufigkeit des anovulatorischen Zyklus im Leben der Frau. Arch Gynäkol. 1963; 199 115-123
- 34 Gebbie A E, Glasier A, Sweeting V. Incidence of ovulation in perimenopausal women before and during hormone replacement therapy. Contraception. 1995; 52 221-222
-
35 Lauritzen C.
Endokrinologie der Prä- und Postmenopause. Lauritzen C Gynäkologische Endokrinologie. Frauenheilkunde und Geburtshilfe. München; Urban und Schwarzenberger 1987: 27 - 36 Lamberts S W, van den Beld A W, van der Lely A J. The endocrinology of aging. Science. 1997; 278 419-424
PD Dr. Andreas Müller
Frauenklinik Universitätsklinikum Erlangen
Universitätsstraße 21 – 23
91054 Erlangen
eMail: andreas.mueller@uk-erlangen.de